Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Synoligo Biotechnologies is an active commercial supplier specializing in high-quality custom synthesis of complex and highly modified oligonucleotides at varying scales. It serves academic institutions, biotech startups, large pharmaceutical companies as well as diagnostic developers. The company has rapidly expanded since its founding in July 2022—including opening new facilities to increase production capacity—and is recognized for fast turnaround times and expertise with challenging modifications[1][3][4].
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Synoligo Biotechnologies.